<i>Conclusions:</i> Our findings indicate that OCT4 and LIN28B are implicated in lung adenocarcinoma progression and prognosis outcome; thus, they serve as promising prognostic biomarkers and putative therapeutic targets in lung adenocarcinomas. This evidence concerns the gene POU5F1 and lung adenocarcinoma.